Contrariwise, using OCTA, long-term administration of intravitreal anti-VEGF injections has been shown to improve or at least maintain retinal perfusion in patients with retinal vein occlusion and diabetic retinopathy.35 Here, VEGFA is linked to diabetic retinopathy.